Skip to content

Clinical trials

Pancreatic Neoplasms trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Country / region: New Zealand Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20051
20101
20141
20191
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Approved for marketing1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation2
Australasian Gastro-Intestinal Trials Group1
Eli Lilly and Company1
Hoffmann-La Roche1
Merck Sharp & Dohme LLC1
NCIC Clinical Trials Group1
OSI Pharmaceuticals1
OncoMed Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms9
Carcinoma, Non-Small-Cell Lung2
Neoplasms2
Breast Neoplasms1
Carcinoma, Medullary1
Colonic Neoplasms1
Colorectal Neoplasms1
Neoplasm Metastasis1
Thyroid Cancer, Papillary1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.